mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0066 |
0.8 |